Asset Dedication LLC decreased its stake in shares of Exelon Co. (NASDAQ:EXC – Free Report) by 92.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 736 shares of the company’s stock after selling 9,194 shares during the period. Asset Dedication LLC’s holdings in Exelon were worth $28,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. Marshall Wace LLP bought a new stake in shares of Exelon during the second quarter worth approximately $1,811,000. AQR Capital Management LLC boosted its stake in Exelon by 147.7% in the 2nd quarter. AQR Capital Management LLC now owns 192,375 shares of the company’s stock valued at $6,641,000 after purchasing an additional 114,697 shares during the period. NewEdge Advisors LLC grew its holdings in Exelon by 1.5% in the 2nd quarter. NewEdge Advisors LLC now owns 31,654 shares of the company’s stock valued at $1,096,000 after buying an additional 455 shares in the last quarter. Strategic Investment Solutions Inc. IL bought a new position in Exelon during the 2nd quarter worth $57,000. Finally, Sanctuary Advisors LLC bought a new stake in shares of Exelon in the second quarter valued at about $1,215,000. Institutional investors and hedge funds own 80.92% of the company’s stock.
Exelon Stock Up 1.1 %
Shares of EXC opened at $40.02 on Friday. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.97 and a current ratio of 1.09. Exelon Co. has a 52 week low of $33.35 and a 52 week high of $41.19. The stock has a market capitalization of $40.21 billion, a price-to-earnings ratio of 16.47, a PEG ratio of 2.61 and a beta of 0.55. The stock has a fifty day moving average of $38.18 and a 200-day moving average of $38.49.
Analyst Ratings Changes
A number of equities analysts recently commented on EXC shares. Barclays lowered their price target on shares of Exelon from $44.00 to $42.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 22nd. Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $43.00 to $44.00 in a research note on Tuesday, January 21st. Morgan Stanley lowered their price objective on Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Friday, November 22nd. Scotiabank raised their price target on Exelon from $40.00 to $42.00 and gave the stock a “sector perform” rating in a research report on Thursday, December 12th. Finally, Guggenheim raised shares of Exelon from a “neutral” rating to a “buy” rating in a research report on Thursday, January 23rd. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $43.13.
Get Our Latest Stock Report on EXC
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Further Reading
- Five stocks we like better than Exelon
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The 3 Best Retail Stocks to Shop for in August
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Earnings Per Share Calculator: How to Calculate EPS
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.